Dividends

REGNRegeneron Pharmaceuticals

StockNasdaqUnited StatesHealth careEU retail investors: available

+1.7% today · +40.6% over a year

10/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 96% of the instruments we score

Quality, Dividend safety: among the best of its peers; priced lower than most peers. Dividend yield 0.40%.

Regeneron Pharmaceuticals (REGN) dividends: trailing yield 0.40%, next ex-dividend date 20 Nov 2026, Dividend Safety 86/100.

Trailing 12-month yieldA high yield can signal risk rather than safety: payouts may be cut, and part of a fund's distribution may be your own capital returned.
0.40%
Forward yield (next or typical regular payment, annualised)
0.41%
Dividends per share, last 12 months
$3.70
Payments per year
4
Dividend safety0–100 points: payout versus earnings and cash flow, debt, cut history, years without a lower dividend and how stretched the yield looks.
86 / 100
Very safe

Yield after tax (estimate)

Before tax → After tax, CY non-dom

Last 12 months
0.40% → 0.33%
Forward
0.41% → 0.34%

Of every 100 paid out

Withheld at source (United States)
15.00%
Cyprus Special Defence Contribution (after credit for foreign tax)
0.00%
Cyprus GeSY health contribution
2.65%
You keep
82.35%
  • Source country assumed: United States (from the issuer’s data). Depositary receipts and companies listed outside their home country may be taxed by that home country.
  • US rate 15 % assumes a W-8BEN form is on file with your broker (US–Cyprus treaty); without it the US withholds 30 %.
  • GeSY 2.65 % applies to dividends and interest of every Cyprus resident, domiciled or not, up to €180,000 of income a year.

Cyprus resident, domiciled: 0.33%

Estimate, not tax advice: published rules as of 2026-10-14 for the profile chosen; your broker’s withholding and your own situation can differ. How we estimate tax

Next payment

Ex-dividend date
20 Nov 2026
Payment date
03 Dec 2026
Amount per share
$0.94
Status
Announced

Dividend profile

Years without a lower dividend
1
Years without a cut of over 10 %
1
Payout ratio (earnings)
8%
Payout ratio (free cash flow)
10%

Payment history

Amounts are per share on today's share count (adjusted for splits), before withholding tax.

Status
20 Nov 202603 Dec 2026$0.94RegularAnnounced2
18 Aug 202601 Sep 2026$0.94RegularVerified3
20 May 202605 Jun 2026$0.94RegularVerified3
20 Feb 202606 Mar 2026$0.94RegularVerified3

Each payment is checked against up to 3 data feeds. Several feeds can share one upstream, so Verified needs two independent ones. Verified: two or more sources agree. Single source: not cross-checked yet. Sources disagree: the median is shown. Announced: declared, may still change.

What dividend safety is made of

0–100 points: payout versus earnings and cash flow, debt, cut history, years without a lower dividend and how stretched the yield looks.

Similar dividend payers

Same sector and region, closest in dividend yield.

UHSUniversal Health Services0.4%766
CHEChemed Corp0.5%9525
HSTMHealthStream Inc.0.5%763
MCKMcKesson0.3%3925
MLABMesa Laboratories Inc0.5%3918
BRKRBruker Corp0.3%6710
TECHBio-Techne0.5%8417
TMOThermo Fisher Scientific0.3%8214

A high yield is not a high return: payouts can come from your own capital and can be cut. Dividend calculator →